Gene	POS	Genomic_coord_start	Genomic_coord_end	Main_ref_codon	Main_alt_codon	Main_ref_residue	Main_alt_residue	NbSample	MeanAF	SARS residue	MainFeat	MainResidue	SecondFeat	SecondResidue	Second_ref_codon	Second_alt_codon	Second_ref_residue	Second_alt_residue	ThirdFeat	ThirdResidue	Third_ref_codon	Third_alt_codon	Third_ref_residue	Third_alt_residue	ORF1ab pos	Annotation	Impact	Reference
"ORF1a 16,leader protein 16"	311	311	313	"CTC,CTT"	"CTT,NNN,CTY"	L	"L,X"	2	0		ORF1a	16	leader protein	16	"CTC,CTT"	"CTT,NNN,CTY"	L	"L,X"	na	na	na	na	na	na	16	leader protein		
"ORF1a 30,leader protein 30"	353	353	355	0	0	G	D	12	0	ORF1a 30	ORF1a	30	leader protein	30	na	na	na	na	na	na	na	na	na	na	30	leader protein		
"ORF1a 84,leader protein 84"	515	515	517	GTT	"NNN,GTG,GNT,GNN"	V	"X,V"	2	0		ORF1a	84	leader protein	84	GTT	"NNN,GTG,GNT,GNN"	V	"X,V"	na	na	na	na	na	na	84	leader protein		
"ORF1a 86,leader protein 86"	521	521	523	"GTT,ATG"	"ATG,NNN,NNT"	"V,M"	"M,X"	2	0		ORF1a	86	leader protein	86	"GTT,ATG"	"ATG,NNN,NNT"	"V,M"	"M,X"	na	na	na	na	na	na	86			
"ORF1a 92,leader protein 92"	539	539	541	"CTT,CTC"	"CTC,MTC,NNN,NTC,CYC,TTC,CTG"	L	"L,J,X,F"	2	0		ORF1a	92	leader protein	92	"CTT,CTC"	"CTC,MTC,NNN,NTC,CYC,TTC,CTG"	L	"L,J,X,F"	na	na	na	na	na	na	92			
"ORF1a 135,leader protein 135"	668	668	670	0	0	S	N	5		leader protein	ORF1a	135	135		na	na	na	na		na	na	na			135	leader protein		
"ORF1a 166,leader protein 166"	761	761	763	AGC	GGC	S	G	4	0	ORF1a 166	ORF1a	166	leader protein	166	AGC	GGC	S	G	na	na	na	na	na	na	166			
"ORF1a 210,nsp2 30"	893	893	895	AAA	AAG	K	K	2	0		ORF1a	210	nsp2	30	AAA	AAG	K	K	na	na	na	na	na	na	210	"nsp2 shown to be dispensable for the viability of coronavirus, MHV P65 homolog"		"10.1007/s13238-010-0028-8, 10.1016/j.str.2004.01.016"
"ORF1a 231,nsp2 51"	956	956	958	0	0	C	Y	3	0	ORF1a 231	ORF1a	231	nsp2	51	na	na	na	na	na	na	na	na	na	na	231	"nsp2 shown to be dispensable for the viability of coronavirus, MHV P65 homolog"		"10.1007/s13238-010-0028-8, 10.1016/j.str.2004.01.016"
"ORF1a 265,nsp2 85"		1058	1060	"AAA,ACC,AAC,ATC"	"ACC,ATC,AAC,AYC,ANC,ATY"	"K,T,N,I"	"T,I,N,X"	6	0	ORF1a 265	ORF1a	265	nsp2	85	"AAA,ACC,AAC,ATC"	"ACC,ATC,AAC,AYC,ANC,ATY"	"K,T,N,I"	"T,I,N,X"	na	na	na	na	na	na	231	"nsp2 shown to be dispensable for the viability of coronavirus, MHV P65 homolog"		"10.1007/s13238-010-0028-8, 10.1016/j.str.2004.01.016"
"ORF1a 274,nsp2 94"	1058	1085	1087	GTA	GTG	V	V	2	0	ORF1a 268	ORF1a	274	nsp2	94	GTA	GTG	V	V	na	na	na	na	na	na	265	"nsp2 shown to be dispensable for the viability of coronavirus, MHV P65 homolog"		"10.1007/s13238-010-0028-8, 10.1016/j.str.2004.01.016"
"ORF1a 268,nsp2 88"	1067	1067	1069	0	0	G	E	4	0	ORF1a 268	ORF1a	268	nsp2	88	na	na	G	E	na	na	na	na	na	na	268	"nsp2 shown to be dispensable for the viability of coronavirus, MHV P65 homolog"		"10.1007/s13238-010-0028-8, 10.1016/j.str.2004.01.016"
"ORF1a 274
nsp2 94"	1085	1085	1087	GTA(V)	GTG(V) 2	V	V				ORF1a	274	nsp2	94	na	na	V	V	na	na	na	na	na	na	274	"nsp2 shown to be dispensable for the viability of coronavirus, MHV P65 homolog"		"10.1007/s13238-010-0028-8, 10.1016/j.str.2004.01.016"
"ORF1a 286,nsp2 106"	1121	1121	1123	CCA	CCG	P	P	4	0		ORF1a	286	nsp2	106	CCA	CCG	P	P	na	na	na	na	na	na	286	"nsp2 shown to be dispensable for the viability of coronavirus, MHV P65 homolog"		"10.1007/s13238-010-0028-8, 10.1016/j.str.2004.01.016"
"ORF1a 333,nsp2 153"	1262	1262	1264	ACG	"ATG,ACT,ACA,GCG"	T	"M,T,A"	2	0		ORF1a	333	nsp2	153	ACG	"ATG,ACT,ACA,GCG"	T	"M,T,A"	na	na	na	na	na	na	333	"nsp2 shown to be dispensable for the viability of coronavirus, MHV P65 homolog"		"nsp2 shown to be dispensable for the viability of coronavirus, MHV P65 homolog"
"ORF1a 374,nsp2 194"	1385	1385	1387	0	0	H	Y	5	0	ORF1a 374	ORF1a	374	nsp2	194	na	na	H	Y	na	na	na	na	na	na	374	"nsp2 shown to be dispensable for the viability of coronavirus, MHV P65 homolog"		"10.1007/s13238-010-0028-8, 10.1016/j.str.2004.01.016"
"ORF1a 392,nsp2 212"	1439	1439	1441	0	0	G	"D,C"	12	0	ORF1a 392	ORF1a	392	nsp2	212	na	na	G	"D,C"	na	na	na	na	na	na	392	"nsp2 shown to be dispensable for the viability of coronavirus, MHV P65 homolog"		"10.1007/s13238-010-0028-8, 10.1016/j.str.2004.01.016"
"ORF1a 398,nsp2 218"	1457	1457	1459	CGT	TGT	R	C	2	0		ORF1a	398	nsp2	218	CGT	TGT	R	C	na	na	na	na	na	na	398	"nsp2 shown to be dispensable for the viability of coronavirus, MHV P65 homolog"		"nsp2 shown to be dispensable for the viability of coronavirus, MHV P65 homolog"
"ORF1a 428,nsp2 248"	1547	1547	1549	AGC	"GGC,AAC"	S	"G,N"	3	0	ORF1a 428	ORF1a	428	nsp2	248	AGC	"GGC,AAC"	S	"G,N"	na	na	na	na	na	na	428	"nsp2 shown to be dispensable for the viability of coronavirus, MHV P65 homolog"		"10.1007/s13238-010-0028-8, 10.1016/j.str.2004.01.016"
"ORF1a 447,nsp2 267"		1604	1606	"AAT,AAC,GAC"	"AAC,GAC,ANN,AAN,NNN,GAA"	"N,D"	"N,D,X,E"	3	0		ORF1a	447	nsp2	267	"AAT,AAC,GAC"	"AAC,GAC,ANN,AAN,NNN,GAA"	"N,D"	"N,D,X,E"	na	na	na	na	na	na	447			
"ORF1a 454,nsp2 274"	1625	1625	1627	CTC	"TTC,NNN"	L	"F,X"	2	0		ORF1a	454	nsp2	274	CTC	"TTC,NNN"	L	"F,X"	na	na	na	na	na	na	454	"nsp2 shown to be dispensable for the viability of coronavirus, MHV P65 homolog"		"10.1007/s13238-010-0028-8, 10.1016/j.str.2004.01.016"
"ORF1a 486,nsp2 306"	1721	1721	1723	GCT	"GTT,TCT,GYT,NNN"	A	"V,S,X"	2	0		ORF1a	486	nsp2	306	GCT	"GTT,TCT,GYT,NNN"	A	"V,S,X"	na	na	na	na	na	na	486	"nsp2 shown to be dispensable for the viability of coronavirus, MHV P65 homolog"		"10.1007/s13238-010-0028-8, 10.1016/j.str.2004.01.016"
"ORF1a 519,nsp2 339"	1820	1820	1822	GGT	"AGT,RGT"	G	"S,X"	4	0	ORF1a 519	ORF1a	519	nsp2	339	GGT	"AGT,RGT"	G	"S,X"	na	na	na	na	na	na	519	"nsp2 shown to be dispensable for the viability of coronavirus, MHV P65 homolog"		"10.1007/s13238-010-0028-8, 10.1016/j.str.2004.01.016"
"ORF1a 549,nsp2 369"		1910	1912	"TCC,TCT"	"TCT,TTC,TYC,TCY"	S	"S,F,X"	2	0		ORF1a	549	nsp2	369	"TCC,TCT"	"TCT,TTC,TYC,TCY"	S	"S,F,X"	na	na	na	na	na	na	549			
"ORF1a 580,nsp2 400"	2003	2003	2005	CTC	TTC	L	F	5	0	ORF1a 580	ORF1a	580	nsp2	400	CTC	TTC	L	F	na	na	na	na	na	na	580	"nsp2 shown to be dispensable for the viability of coronavirus, MHV P65 homolog"		"10.1007/s13238-010-0028-8, 10.1016/j.str.2004.01.016"
"ORF1a 609,nsp2 429"	2090	2090	2092	"ACT,ATT"	"ATT,AYT"	"T,I"	"I,X"	2	0		ORF1a	609	nsp2	429	"ACT,ATT"	"ATT,AYT"	"T,I"	"I,X"	na	na	na	na	na	na	609	"nsp2 shown to be dispensable for the viability of coronavirus, MHV P65 homolog"		"10.1007/s13238-010-0028-8, 10.1016/j.str.2004.01.016"
"ORF1a 650,nsp2 470"	2213	2213	2215	AAA	"AAG,AAC,NNN"	K	"K,N,X"	2	0		ORF1a	650	nsp2	470	AAA	"AAG,AAC,NNN"	K	"K,N,X"	na	na	na	na	na	na	650	"nsp2 shown to be dispensable for the viability of coronavirus, MHV P65 homolog"		"10.1007/s13238-010-0028-8, 10.1016/j.str.2004.01.016"
"ORF1a 652,nsp2 472"	2219	2219	2221	ATC	"GTC,NNN"	I	"V,X"	2	0		ORF1a	652	nsp2	472	ATC	"GTC,NNN"	I	"V,X"	na	na	na	na	na	na	652	"nsp2 shown to be dispensable for the viability of coronavirus, MHV P65 homolog"		"10.1007/s13238-010-0028-8, 10.1016/j.str.2004.01.016"
"ORF1a 660,nsp2 480"	2243	2243	2245	gGt	gTt	G	V	5	0	ORF1a 660	ORF1a	660	nsp2	480	na	na	na	na	na	na	na	na	na	na	660	"nsp2 shown to be dispensable for the viability of coronavirus, MHV P65 homolog"		"10.1007/s13238-010-0028-8, 10.1016/j.str.2004.01.016"
"ORF1a 717,nsp2 537"	2414	2414	2416	"TAC,TAT"	"TAT,TAY,TAN,NNN"	Y	"Y,X"	2	0		ORF1a	717	nsp2	537	"TAC,TAT"	"TAT,TAY,TAN,NNN"	Y	"Y,X"	na	na	na	na	na	na	717	"nsp2 shown to be dispensable for the viability of coronavirus, MHV P65 homolog"		"10.1007/s13238-010-0028-8, 10.1016/j.str.2004.01.016"
"ORF1a 748,nsp2 568"	2507	2507	2509	CCC	"CTC,TCC,CCT"	P	"L,S,P"	2	0		ORF1a	748	nsp2	568	CCC	"CTC,TCC,CCT"	P	"L,S,P"	na	na	na	na	na	na	748	"nsp2 shown to be dispensable for the viability of coronavirus, MHV P65 homolog"		"10.1007/s13238-010-0028-8, 10.1016/j.str.2004.01.016"
"ORF1a 872,nsp3 54"	2879	2879	2881	GCC	"GTC,TCC"	A	"V,S"	2	0		ORF1a	872	nsp3	54	GCC	"GTC,TCC"	A	"V,S"	na	na	na	na	na	na	872			
"ORF1a 892,nsp3 74"	2939	2939	2941	CCA	"CTA,TCA"	P	"L,S"	2	0	ORF1a 893	ORF1a	892	nsp3	74	CCA	"CTA,TCA"	P	"L,S"	na	na	na	na	na	na	892	"PLpro, Glu-rich acidic acidic (AD) domain, interacts with GST-nsp9 "		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 894,nsp3 76"	2945	2945	2947	GGC	"AGC,TGC,RGC"	G	"S,C,X"	2	0		ORF1a	894	nsp3	76	GGC	"AGC,TGC,RGC"	G	"S,C,X"	na	na	na	na	na	na	894			
"ORF1a 924,nsp3 106"	3035	3035	3037	"TTT,TTC"	"TTC,TTY,TTA,TWC"	F	"F,L,X"	5	0		ORF1a	924	nsp3	106	"TTT,TTC"	"TTC,TTY,TTA,TWC"	F	"F,L,X"	na	na	na	na	na	na	924	"PLpro, Glu-rich acidic acidic (AD) domain, interacts with GST-nsp9 "		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017, 10.1016/j.ygeno.2020.04.016"
"ORF1a 960,nsp3 142"	3143	3143	3145	0	0	L	"F,S"	11	0	ORF1a 962	ORF1a	960	nsp3	142	na	na	L	"F,S"	na	na	na	na	na	na	960	"PLpro, Glu-rich acidic acidic (AD)  domain, interacts with GST-nsp9 "		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 1100,nsp3 282"	3563	3563	3565	"GGT,GTT"	"GTT,GKT,GGK,GNT"	"G,V"	"V,X,G"	3	0	ORF1a 1078	ORF1a	1100	nsp3	282	"GGT,GTT"	"GTT,GKT,GGK,GNT"	"G,V"	"V,X,G"	na	na	na	na	na	na	1100	"PLpro, X domain with poly(ADP-ribose) binding properties"		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 1143,nsp3 325"	3692	3692	3694	GTT	"TTT,KTT"	V	"F,X"	2	0		ORF1a	1143	nsp3	325	GTT	"TTT,KTT"	V	"F,X"	na	na	na	na	na	na	1143	"PLpro, X domain with poly(ADP-ribose) binding properties"		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 1158,nsp3 340"	3737	3737	3739	"CCT,CTT"	"CTT,TCT,CYT"	"P,L"	"L,S,X"	2	0		ORF1a	1158	nsp3	340	"CCT,CTT"	"CTT,TCT,CYT"	"P,L"	"L,S,X"	na	na	na	na	na	na	1158	"PLpro, X domain with poly(ADP-ribose) binding properties"		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 1160,nsp3 342"	3743	3743	3745	CAT	"TAT,CAN"	H	"Y,X"	2	0		ORF1a	1160	nsp3	342	CAT	"TAT,CAN"	H	"Y,X"	na	na	na	na	na	na	1160	"PLpro, X domain with poly(ADP-ribose) binding properties"		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 1168,nsp3 350"	3767	3767	3769	"ACT,ATT"	"ATT,AYT,AYY"	"T,I"	"I,X"	2	0		ORF1a	1168	nsp3	350	"ACT,ATT"	"ATT,AYT,AYY"	"T,I"	"I,X"	na	na	na	na	na	na	1168	"PLpro, X domain with poly(ADP-ribose) binding properties"		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 1202,nsp3 384"	3869	3869	3871	AAG	AAT	K	N	2	0		ORF1a	1202	nsp3	384	AAG	AAT	K	N	na	na	na	na	na	na	1202	SUD Domain		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 1208,nsp3 390"	3887	3887	3889	AAA	AAG	K	K	2	0		ORF1a	1208	nsp3	390	AAA	AAG	K	K	na	na	na	na	na	na	1208	"SUDcore (for SARS-CoV Unique Domain, an insertion not found in any other coronavirus thus far) "		10.1371/journal.ppat.1000428
"ORF1a 1250,nsp3 432"		4013	4015	ACA	"ACT,ACG"	T	T	2	0		ORF1a	1250	nsp3	432	ACA	"ACT,ACG"	T	T	na	na	na	na	na	na	1250			
"ORF1a 1262, nsp3 444"	4049	4049	4051	Ctt	Ttt	L	F	2	0	ORF1a 1238	ORF1a	1262	nsp3	444	na	na	na	na	na	na	na	na			1262	"PLpro, SUDcore with a specific affinity for oligo(G)-strings , interacts with GST-nsp9, The N-terminal subdomain (SUD-N)"		"10.1128/jvi.00017-07, https://dx.plos.org/10.1371/journal.ppat.1000428, 10.1016/j.virusres.2007.11.017"
"ORF1a 1330,nsp3 512"		4253	4255	CCG	"CCT,CCA"	P	P	3	0		ORF1a	1330	nsp3	512	CCG	"CCT,CCA"	P	P	na	na	na	na	na	na	1330			
"ORF1a 1352,nsp3 534"	4319	4319	4321	GCC	"GTC,RCC,GCT"	A	"V,X,A"	2	0		ORF1a	1352	nsp3	534	GCC	"GTC,RCC,GCT"	A	"V,X,A"	na	na	na	na	na	na	1352	"PLpro, SUDcore with a specific affinity for oligo(G)-strings , interacts with GST-nsp9. middle SUD subdomain (SUD-M)"		10.1371/journal.ppat.1000428
"ORF1a 1375,nsp3 557"	4388	4388	4390	0	0	L	F	6	0	ORF1a 1351	ORF1a	1375	nsp3	557	na	na	L	F	na	na	na	na	na	na	1375	"PLpro, SUDcore with a specific affinity for oligo(G)-strings , interacts with GST-nsp9. middle SUD subdomain (SUD-M)"		"10.1128/jvi.00017-07, https://dx.plos.org/10.1371/journal.ppat.1000428, 10.1016/j.virusres.2007.11.017"
"ORF1a 1415,nsp3 597"	4508	4508	4510	GTG	"GTT,GTC,GNN,GTA,ATG"	V	"V,X,M"	2	0		ORF1a	1415	nsp3	597	GTG	"GTT,GTC,GNN,GTA,ATG"	V	"V,X,M"	na	na	na	na	na	na	1415	"PLpro, SUDcore with a specific affinity for oligo(G)-strings , interacts with GST-nsp10. middle SUD subdomain (SUD-M)"		"10.1128/jvi.00017-07, https://dx.plos.org/10.1371/journal.ppat.1000428, 10.1016/j.virusres.2007.11.017"
"ORF1a 1464,nsp3 646"	4655	4655	4657	0	0	R	P	4	0	ORF1a 1464	ORF1a	1464	nsp3	646	na	na	R	P	na	na	na	na	na	na	1464	"PLpro, SUDcore with a specific affinity for oligo(G)-strings , interacts with GST-nsp9. middle SUD subdomain (SUD-M)"		"10.1128/jvi.00017-07, https://dx.plos.org/10.1371/journal.ppat.1000428, 10.1016/j.virusres.2007.11.017"
"ORF1a 1599,nsp3 781"	5060	5060	5062	0	0	L	F	11	0	ORF1a 1576	ORF1a	1599	nsp3	781	na	na	L	F	na	na	na	na	na	na	1599	"PLpro, papain-like proteinase (PLP2) domain, interacts with GST-nsp9 "		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 1640,nsp3 822"	5183	5183	5185	CCT	"TCT,CTT,CNN,CYT"	P	"S,L,X"	2	0		ORF1a	1640	nsp3	822	CCT	"TCT,CTT,CNN,CYT"	P	"S,L,X"	na	na	na	na	na	na	1640	"PLpro, PLP2 domain, interacts with GST-nsp9 "		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 1781,nsp3 963"	5606	5606	5608			K		5				1781	nsp3	963	na	na	K		na	na	na	na	na	na	1781	"PLpro, PLP2 domain, interacts with GST-nsp9 "		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 1822,nsp3 1004"	5729	5729	5731	ACT	ATT	T	I	2	0		ORF1a	1822	nsp3	1004	ACT	ATT	T	I	na	na	na	na	na	na	1822	"PLpro, PLP2 domain, interacts with GST-nsp9 "		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 1840,nsp3 1022"	5783	5783	5785	ACT	"ATT,AYT"	T	"I,X"	2	0		ORF1a	1840	nsp3	1022	ACT	"ATT,AYT"	T	"I,X"	na	na	na	na	na	na	1840	"PLpro, PLP2 domain, interacts with GST-nsp9 "		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 1921,nsp3 1103"	6026	6026	6028	CCA	"CTA,TCA"	P	"L,S"	2	0		ORF1a	1921	nsp3	1103	CCA	"CTA,TCA"	P	"L,S"	na	na	na	na	na	na	1921	"PLpro, PLP2 domain, interacts with GST-nsp9 "		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 1997,nsp3 1179"	6254	6254	6256	0	0	A	V	2	0	ORF1a 1974	ORF1a	1997	nsp3	1179	na	na	A	V	na	na	na	na	na	na	1997	"PLpro, PLP2 domain, papain-like noncanonical (PLnc), exhibit deubiquitinating activity, interacts with GST-nsp9 "		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 2016,nsp3 1198"	6311	6311	6313	0	0	T	I	4	0	ORF1a 1993	ORF1a	2016	nsp3	1198	na	na	T	I	na	na	na	na	na	na	2016	"PLpro, PLP2 domain, papain-like noncanonical (PLnc), exhibit deubiquitinating activity, interacts with GST-nsp9 "		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 2062,nsp3 1244"	6449	6449	6451	CTT	"TTT,CTY,NTT"	L	"F,L,X"	2	0		ORF1a	2062	nsp3	1244	CTT	"TTT,CTY,NTT"	L	"F,L,X"	na	na	na	na	na	na	2062	"PLpro, PLnc domain"		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 2067,nsp3 1249"	6464	6464	6466	AAA	AAG	K	K	2	0		ORF1a	2067	nsp3	1249	AAA	AAG	K	K	na	na	na	na	na	na	2067	"PLpro, PLnc domain"		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 2098,nsp3 1280"	6557	6557	6559	GCT	GTT	A	V	2	0		ORF1a	2098	nsp3	1280	GCT	GTT	A	V	na	na	na	na	na	na	2098	"PLpro, PLnc domain"		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 2124,nsp3 1306"	6635	6635	6637	ACT	"ATT,NNN"	T	"I,X"	4	0	ORF1a 2101	ORF1a	2124	nsp3	1306	ACT	"ATT,NNN"	T	"I,X"	na	na	na	na	na	na	2124	"PLpro, papain-like noncanonical (PLnc)"		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 2144,nsp3 1326"	6695	6695	6697	CCT	"CTT,ACT,TCT"	P	"L,T,S"	3	0	ORF1a 2121	ORF1a	2144	nsp3	1326	CCT	"CTT,ACT,TCT"	P	"L,T,S"	na	na	na	na	na	na	2144	"PLpro, papain-like noncanonical (PLnc) domain, interacts with GST-nsp9 , "		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 2153,nsp3 1335"	6722	6722	6724	ACT	ATT	T	I	2	0	ORF1a 2130	ORF1a	2153	nsp3	1335	ACT	ATT	T	I	na	na	na	na	na	na	2153	"PLpro, papain-like noncanonical (PLnc)"		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 2242,nsp3 1424"	6989	6989	6991	TCT	"TTT,CCT,TYT,NNN"	S	"F,P,X"	3	0	ORF1a 2219	ORF1a	2242	nsp3	1424	TCT	"TTT,CCT,TYT,NNN"	S	"F,P,X"	na	na	na	na	na	na	2242	"PLpro, Y domain, transmembrane domain, interacts with GST-nsp9 , Y domain has “no obvious role in RNA synthesis. Therefore, it is logical to propose that they may rather play a role in virus-host interactions to, e.g. modulate immunity and/or pathogenesis.”"		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 2249,nsp3 1431"	7010	7010	7012	GCT	"GTT,NNN,GYT"	A	"V,X"	5	0	2226	ORF1a	2249	nsp3	1431	GCT	"GTT,NNN,GYT"	A	"V,X"	na	na	na	na	na	na	2249	"PLpro, Y domain, transmembrane domain, interacts with GST-nsp9 , Y domain has “no obvious role in RNA synthesis. Therefore, it is logical to propose that they may rather play a role in virus-host interactions to, e.g. modulate immunity and/or pathogenesis.”"		"10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 2391,nsp3 1573"		7436	7438	TAT	"TAC,NNN"	Y	"Y,X"	2	0		ORF1a	2391	nsp3	1573	TAT	"TAC,NNN"	Y	"Y,X"	na	na	na	na	na	na	2391			
"ORF1a 2405,nsp3 1587"	7478	7478	7480	"AAT,AGT"	"AGT,NNN,ART"	"N,S"	"S,X"	2	0	2382	ORF1a	2405	nsp3	1587	"AAT,AGT"	"AGT,NNN,ART"	"N,S"	"S,X"	na	na	na	na	na	na	2405	"PLpro, Catalytic domain, Y domain, Y domain has “no obvious role in RNA synthesis. Therefore, it is logical to propose that they may rather play a role in virus-host interactions to, e.g. modulate immunity and/or pathogenesis.”"		"10.1002/cmdc.202000223, 10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 2470,nsp3 1652"	7673	7673	7675	GCG	GCT	A	A	2	0	2447	ORF1a	2470	nsp3	1652	GCG	GCT	A	A	na	na	na	na	na	na	2470	"PLpro, Catalytic domain, Y domain, Y domain has “no obvious role in RNA synthesis. Therefore, it is logical to propose that they may rather play a role in virus-host interactions to, e.g. modulate immunity and/or pathogenesis.”"		"10.1002/cmdc.202000223, 10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 2497,nsp3 1679"	7754	7754	7756	AAG	"AAT,AGG"	K	"N,R"	2	0	2474	ORF1a	2497	nsp3	1679	AAG	"AAT,AGG"	K	"N,R"	na	na	na	na	na	na	2497	"PLpro, Catalytic domain, Y domain, Y domain has “no obvious role in RNA synthesis. Therefore, it is logical to propose that they may rather play a role in virus-host interactions to, e.g. modulate immunity and/or pathogenesis.”"		"10.1002/cmdc.202000223, 10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 2500,nsp3 1682"	7763	7763	7765	TCC	"TCT,TTC"	S	"S,F"	2	0	2477	ORF1a	2500	nsp3	1682	TCC	"TCT,TTC"	S	"S,F"	na	na	na	na	na	na	2500	"PLpro, Catalytic domain, Y domain, Y domain has “no obvious role in RNA synthesis. Therefore, it is logical to propose that they may rather play a role in virus-host interactions to, e.g. modulate immunity and/or pathogenesis.”"		"10.1002/cmdc.202000223, 10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 2557,nsp3 1739"	7934	7934	7936	GCG	"GCT,GCR"	A	A	2	0	2534	ORF1a	2557	nsp3	1739	GCG	"GCT,GCR"	A	A	na	na	na	na	na	na	2557	"PLpro, Catalytic domain, Y domain, Y domain has “no obvious role in RNA synthesis. Therefore, it is logical to propose that they may rather play a role in virus-host interactions to, e.g. modulate immunity and/or pathogenesis.”"		"10.1002/cmdc.202000223, 10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 2575,nsp3 1757"		7988	7990	GCA	"GCT,GCC"	A	A	2	0		ORF1a	2575	nsp3	1757	GCA	"GCT,GCC"	A	A	na	na	na	na	na	na	2575			na
"ORF1a 2635,nsp3 1817"	8168	8168	8170	TCA	TCG	S	S	2	0	2612	ORF1a	2635	nsp3	1817	TCA	TCG	S	S	na	na	na	na	na	na	2635	"PLpro, Catalytic domain, Y domain, Y domain has “no obvious role in RNA synthesis. Therefore, it is logical to propose that they may rather play a role in virus-host interactions to, e.g. modulate immunity and/or pathogenesis.”"		"10.1002/cmdc.202000223, 10.1128/jvi.00017-07, 10.1016/j.virusres.2007.11.017"
"ORF1a 2796,nsp4 33"	8651	8651	8653	"ATG,ATT"	"CTG,ATT,NNN,MTG,ATC,ANN,GTG"	"M,I"	"L,I,X,V"	2	0	2773	ORF1a	2796	nsp4	33	"ATG,ATT"	"CTG,ATT,NNN,MTG,ATC,ANN,GTG"	"M,I"	"L,I,X,V"	na	na	na	na	na	na	2796			
"ORF1a 2839,nsp4 76"		8780	8782	"AGT,AGC"	"AGC,AGN,AGY"	S	"S,X"	2	0		ORF1a	2839	nsp4	76	"AGT,AGC"	"AGC,AGN,AGY"	S	"S,X"	na	na	na	na	na	na	2839			
"ORF1a 2842,nsp4 79"	8789	8789	8791	"GGT,GTT"	"GTT,GKT"	"G,V"	"V,X"	3	0	ORF1a 2819	ORF1a	2842	nsp4	79	"GGT,GTT"	"GTT,GKT"	"G,V"	"V,X"	na	na	na	na	na	na	2842			
"ORF1a 2949,nsp4 186"	9110	9110	9112	0	0	R	H	6	0	2926	ORF1a	2949	nsp4	186	na	na	na	na	na	na	na	na			2949			
"ORF1a 3027,nsp4 264"	9344	9344	9346	CTT	TTT	L	F	2	0		ORF1a	3027	nsp4	264	CTT	TTT	L	F	na	na	na	na	na	na	3027			
"ORF1a 3058,nsp4 295"	9437	9437	9439	ACA	"ATA,TCA,AYA"	T	"I,S,X"	2	0		ORF1a	3058	nsp4	295	ACA	"ATA,TCA,AYA"	T	"I,S,X"	na	na	na	na	na	na	3058			
"ORF1a 3070,nsp4 307"	9473	9473	9475	"GCT,GTT"	"GTT,GNT,GCN,GYT,GCW"	"A,V"	"V,X,A"	2	0		ORF1a	3070	nsp4	307	"GCT,GTT"	"GTT,GNT,GCN,GYT,GCW"	"A,V"	"V,X,A"	na	na	na	na	na	na	3070			
"ORF1a 3071,nsp4 308"	9476	9476	9478	TTT	"TAT,NTT"	F	"Y,X"	2	0		ORF1a	3071	nsp4	308	TTT	"TAT,NTT"	F	"Y,X"	na	na	na	na	na	na	3071			
"ORF1a 3072,nsp4 309"	9479	9479	9481	"GGT,TGT"	"TGT,KGT,WGT"	"G,C"	"C,X"	2	0		ORF1a	3072	nsp4	309	"GGT,TGT"	"TGT,KGT,WGT"	"G,C"	"C,X"	na	na	na	na	na	na	3072			
"ORF1a 3076,nsp4 313"	9491	9491	9493	CAT	"TAT,YAT"	H	"Y,X"	2	0		ORF1a	3076	nsp4	313	CAT	"TAT,YAT"	H	"Y,X"	na	na	na	na	na	na	3076			
"ORF1a 3090,nsp4 327"	9533	9533	9535	ACT	"AAT,ATT,NNN"	T	"N,I,X"	2	0		ORF1a	3090	nsp4	327	ACT	"AAT,ATT,NNN"	T	"N,I,X"	na	na	na	na	na	na	3090			
"ORF1a 3227,nsp4 464"	9944	9944	9946	AGA	"AGG,AGW"	R	"R,X"	2	0		ORF1a	3227	nsp4	464	AGA	"AGG,AGW"	R	"R,X"	na	na	na	na	na	na	3227			
"ORF1a 3278,3C-like proteinase 15"	10097	10097	10099	"GGT,AGT"	"AGT,NGT,GAT"	"G,S"	"S,X,D"	2	0		ORF1a	3278	3C-like proteinase	15	"GGT,AGT"	"AGT,NGT,GAT"	"G,S"	"S,X,D"	na	na	na	na	na	na	3278	Two beta barrel Catalytic fold 		10.1021/bi0616302
"ORF1a 3308,3C-like proteinase 45"	10187	10187	10189	ACC	ATC	T	I	2	0		ORF1a	3308	3C-like proteinase	45	ACC	ATC	T	I	na	na	na	na	na	na	3308	Two beta barrel Catalytic fold 		10.1021/bi0616302
"ORF1a 3323,3C-like proteinase 60"	10232	10232	10234	CGT	TGT	R	C	2	0		ORF1a	3323	3C-like proteinase	60	CGT	TGT	R	C	na	na	na	na	na	na	3323	Two beta barrel Catalytic fold 		10.1021/bi0616302
"ORF1a 3353,3C-like proteinase 90"	10322	10322	10324	AAG	AGG	K	R	4	0	ORF1a 3330	ORF1a	3353	3C-like proteinase	90	AAG	AGG	K	R	na	na	na	na	na	na	3353	Two beta barrel Catalytic fold 		"10.1016/j.pbiomolbio.2018.08.009, 10.1021/bi0616302"
"ORF1a 3357,3C-like proteinase 94"	10334	10334	10336	GCC	GTC	A	V	2	0		ORF1a	3357	3C-like proteinase	94	GCC	GTC	A	V	na	na	na	na	na	na	3357	"Variable position between SARS(S) and SARS2(A), Two beta barrel Catalytic fold  "		10.12688/f1000research.22457.2
"ORF1a 3447,3C-like proteinase 184"	10604	10604	10606	CCT	"TCT,CCN,CTT"	P	"S,P,L"	2	0		ORF1a	3447	3C-like proteinase	184	CCT	"TCT,CCN,CTT"	P	"S,P,L"	na	na	na	na	na	na	3447	Two beta barrel Catalytic fold 		10.1021/bi0616302
"ORF1a 3483,3C-like proteinase 220"	10712	10712	10714	CTC	TTC	L	F	5	0	ORF1a 3460	ORF1a	3483	3C-like proteinase	220	CTC	TTC	L	F	na	na	na	na	na	na	3483	Globular domain		10.1021/bi0616302
"ORF1a 3497,3C-like proteinase 234"	10754	10754	10756	GCT	"ACT,GTT"	A	"T,V"	2	0		ORF1a	3497	3C-like proteinase	234	GCT	"ACT,GTT"	A	"T,V"	na	na	na	na	na	na	3497	Globular domain		10.1021/bi0616302
"ORF1a 3512,3C-like proteinase 249"	10799	10799	10801	ATA	ATT	I	I	2	0		ORF1a	3512	3C-like proteinase	249	ATA	ATT	I	I	na	na	na	na	na	na	3512	Globular domain		10.1021/bi0616302
"ORF1a 3542,3C-like proteinase 279"	10889	10889	10891	CGT	TGT	R	C	2	0		ORF1a	3542	3C-like proteinase	279	CGT	TGT	R	C	na	na	na	na	na	na	3542	Globular domain		10.1021/bi0616302
"ORF1a 3580,nsp6 11"	11003	11003	11005	"CAC,TAC"	"TAC,GAC"	"H,Y"	"Y,D"	2	0		ORF1a	3580	nsp6	11	"CAC,TAC"	"TAC,GAC"	"H,Y"	"Y,D"	na	na	na	na	na	na	3580			
"ORF1a 3603,nsp6 34"	11072	11072	11074	"TTC,TTT"	"TTT,TTN,TTY"	F	"F,X"	5	0		ORF1a	3603	nsp6	34	"TTC,TTT"	"TTT,TTN,TTY"	F	"F,X"	na	na	na	na	na	na	3603			
"ORF1a 3606,nsp6 37"	11081	11081	11083	"TTG,TTT"	"TTT,TTK,TTN"	"L,F"	"F,X"	6	0	ORF1a 3583	ORF1a	3606	nsp6	37	"TTG,TTT"	"TTT,TTK,TTN"	"L,F"	"F,X"	na	na	na	na	na	na	3606	Identified mutation		"10.1186/s12967-020-02344-6, 10.1016/j.ygeno.2020.04.016"
"ORF1a 3639,nsp6 70"	11180	11180	11182	TTT	TTC	F	F	2	0		ORF1a	3639	nsp6	70	TTT	TTC	F	F	na	na	na	na	na	na	3639			
"ORF1a 3644,nsp6 75"	11195	11195	11197	CTT	TTT	L	F	2	0		ORF1a	3644	nsp6	75	CTT	TTT	L	F	na	na	na	na	na	na	3644			
"ORF1a 3714,nsp6 145"	11405	11405	11407	GTC	"ATC,STC"	V	"I,X"	4	0	ORF1a 3691	ORF1a	3714	nsp6	145	GTC	"ATC,STC"	V	"I,X"	na	na	na	na	na	na	3714	Epitope HLA locus A group 2 subtype 2:01		10.1101/2020.03.30.016931
"ORF1a 3725,nsp6 156"	11438	11438	11440	AAT	"GAT,AGT"	N	"D,S"	2	0		ORF1a	3725	nsp6	156	AAT	"GAT,AGT"	N	"D,S"	na	na	na	na	na	na	3725			
"ORF1a 3755,nsp6 186"	11528	11528	11530	GCC	"ACC,SCC"	A	"T,X"	4	0	ORF1a 3732	ORF1a	3755	nsp6	186	GCC	"ACC,SCC"	A	"T,X"	na	na	na	na	na	na	3755			
"ORF1a 3757,nsp6 188"	11534	11534	11536	"GGT,GTT"	"GTT,AGT,GKT"	"G,V"	"V,S,X"	3	0	ORF1a 3734	ORF1a	3757	nsp6	188	"GGT,GTT"	"GTT,AGT,GKT"	"G,V"	"V,S,X"	na	na	na	na	na	na	3757			
"ORF1a 3777,nsp6 208"	11594	11594	11596	CAG	"CGG,CAT,CRG"	Q	"R,H,X"	2	0		ORF1a	3777	nsp6	208	CAG	"CGG,CAT,CRG"	Q	"R,H,X"	na	na	na	na	na	na	3777			
"ORF1a 3839,nsp6 270"	11780	11780	11782			K	R	2			ORF1a	3839	nsp6	270	na	na	na	na	na	na	na	na			3839			
"ORF1a 3856,nsp6 287"	11831	11831	11833	GCC	"ACC,GTC,GCT,TCC,GCN,GCY"	A	"T,V,A,S"	2	0		ORF1a	3856	nsp6	287	GCC	"ACC,GTC,GCT,TCC,GCN,GCY"	A	"T,V,A,S"	na	na	na	na	na	na	3856			
"ORF1a 3858,nsp6 289"	11837	11837	11839	"GTG,GTA"	"GTA,NNN,TTA,KTA"	V	"V,X,L"	2	0		ORF1a	3858	nsp6	289	"GTG,GTA"	"GTA,NNN,TTA,KTA"	V	"V,X,L"	na	na	na	na	na	na	3858			
"ORF1a 3870,nsp7 11"		11873	11875	GTA	"GTG,NNN"	V	"V,X"	2	0		ORF1a	3870	nsp7	11	GTA	"GTG,NNN"	V	"V,X"	na	na	na	na	na	na	3870			
"ORF1a 3884,nsp7 25"	11960	11915	11917	"TCA,TTA"	"TTA,TYA"	"S,L"	"L,X"	2	0		ORF1a	3884	nsp7	25	"TCA,TTA"	"TTA,TYA"	"S,L"	"L,X"	na	na	na	na	na	na	3884	Helix HB2 		10.1038/nsmb999. 10.1038/s41467-019-10280-3
"ORF1a 3899,nsp7 40"	11960	11960	11962	CTC	"CTT,TTC,ATC"	L	"L,F,I"	2	0		ORF1a	3899	nsp7	40	CTC	"CTT,TTC,ATC"	L	"L,F,I"	na	na	na	na	na	na	3899	Helix HB2 		10.1038/nsmb999. 10.1038/s41467-019-10280-3
"ORF1a 3958,nsp8 16"	12137	12137	12139	GCT	GTT	A	V	2	0		ORF1a	3958	nsp8	16	GCT	GTT	A	V	na	na	na	na	na	na	3958	"Chain G, ‘shaft N-ter domain’"		10.1038/nsmb999. 10.1038/s41467-019-10280-3
"ORF1a 3983,nsp8 41"	12212	12212	12214	TCT	TTT	S	F	2	0		ORF1a	3983	nsp8	41	TCT	TTT	S	F	na	na	na	na	na	na	3983	"Chain G, ‘shaft N-ter domain’"		10.1038/nsmb999. 10.1038/s41467-019-10280-3
"ORF1a 4023,nsp8 81"		12332	12334	GCA	GCT	A	A	2	0		ORF1a	4023	nsp8	81	GCA	GCT	A	A	na	na	na	na	na	na	4023			
"ORF1a 4097,nsp8 155"	12554	12554	12556	GAA	GAG	E	E	2	0		ORF1a	4097	nsp8	155	GAA	GAG	E	E	na	na	na	na	na	na	4097	"Chain H, ‘head’ C-ter domain"		10.1038/nsmb999. 10.1038/s41467-019-10280-3
"ORF1a 4177,nsp9 37"	12794	12794	12796	GGA	"GGC,TGT,GGG"	G	"G,C"	2	0		ORF1a	4177	nsp9	37	GGA	"GGC,TGT,GGG"	G	"G,C"	na	na	na	na	na	na	4177	RNA-Binding protein		10.1038/nsmb999
"ORF1a 4220,nsp9 80"	12923	12923	12925	CCT	"TCT,ACT,YCT"	P	"S,T,X"	2	0		ORF1a	4220	nsp9	80	CCT	"TCT,ACT,YCT"	P	"S,T,X"	na	na	na	na	na	na	4220	RNA-Binding protein		10.1038/nsmb999
"ORF1a 4379,nsp10 126"	13400	13400	13402	TAT	"TTA,NNN,TAN,NAT,TAK,TAW"	Y	"L,X"	2	0		ORF1a	4379	nsp10	126	TAT	"TTA,NNN,TAN,NAT,TAK,TAW"	Y	"L,X"	na	na	na	na	na	na	4379			
"ORF1a 4381,nsp10 128"	13406	13406	13408	"TGT,TGG"	"TGG,TGC,CTG,TGK,TGN"	"C,W"	"W,C,L,X"	2	0		ORF1a	4381	nsp10	128	"TGT,TGG"	"TGG,TGC,CTG,TGK,TGN"	"C,W"	"W,C,L,X"	na	na	na	na	na	na	4381			
"ORF1a 4389,nsp10 136"	13430	13430	13432	CCC	"TCC,ACC"	P	"S,T"	2	0		ORF1a	4389	nsp10	136	CCC	"TCC,ACC"	P	"S,T"	na	na	na	na	na	na	4389			
"ORF1b 14,RdRp 24"		13510	13512	ACA	"ACT,ATA,GCA"	T	"T,I,A"	2	0		ORF1b	14	RdRp	24	ACA	"ACT,ATA,GCA"	T	"T,I,A"	ORF1ab	4394	ACA	"ACT,ATA,GCA"	T	"T,I,A"	4394			
"ORF1b 15,RdRp 25"	13513	13513	13515	"GGC,TGC"	"TGC,TAC,GGT"	"G,C"	"C,Y,G"	4	0	"RdRp 25, ORF1a 4372"	ORF1b	15	RdRp	25	"GGC,TGC"	"TGC,TAC,GGT"	"G,C"	"C,Y,G"	ORF1ab	4395	"GGC,TGC"	"TGC,TAC,GGT"	"G,C"	"C,Y,G"	4395	"NiRAN, NTD ()N terminal Domain)"		"10.1371/journal.ppat.1000428, 10.1126/science.abb7498, 10.1093/nar/gkg916"
"ORF1b 53,RdRp 63"	13627	13627	13629	"GAC,TAC"	"TAC,KAC"	"D,Y"	"Y,X"	5	0	"RdRp 63, ORF1a 4410"	ORF1b	53	RdRp	63	"GAC,TAC"	"TAC,KAC"	"D,Y"	"Y,X"	ORF1ab	4433	"GAC,TAC"	"TAC,KAC"	"D,Y"	"Y,X"	4433	"NiRAN, NTD"		"10.1371/journal.ppat.1000428, 10.1016/j.virusres.2017.01.023, 10.1126/science.abb7498 10.1093/nar/gkg916"
"ORF1b 87,RdRp 97"	13729	13729	13731	GCT	GTT	A	V	4	0	"RdRp 97, ORF1a 4444"	ORF1b	87	RdRp	97	GCT	GTT	A	V	ORF1ab	4467	GCT	GTT	A	V	4467	"NiRAN, NTD,  RNA interaction in RNA binding channel"		"10.1371/journal.ppat.1000428, 10.1126/science.abb7498 10.1093/nar/gkg916, 10.1074/jbc.ra120.013679"
"ORF1b 118,RdRp 128"	13822	13822	13824	GTC	ATC	V	I	2	0	"RdRp	128, , ORF1a "	ORF1b	118	RdRp	128	GTC	ATC	V	I	ORF1ab	4498	GTC	ATC	V	I	4498	"NiRAN, NTD"		"10.1371/journal.ppat.1000428, 10.1126/science.abb7498 10.1093/nar/gkg916"
"ORF1b 151,RdRp 161"	13921	13921	13923	"GAC,TAC"	"TAC,GTC,KAC"	"D,Y"	"Y,V,X"	2	0	"RdRp	161 , ORF1a "	ORF1b	151	RdRp	161	"GAC,TAC"	"TAC,GTC,KAC"	"D,Y"	"Y,V,X"	ORF1ab	4531	"GAC,TAC"	"TAC,GTC,KAC"	"D,Y"	"Y,V,X"	4531	"NiRAN, NTD"		"10.1371/journal.ppat.1000428, 10.1126/science.abb7498 10.1093/nar/gkg916"
"ORF1b 159,RdRp 169"	13945	13945	13947	CCA	"CCT,CYA"	P	"P,X"	4	0	"RdRp	169, ORF1a "	ORF1b	159	RdRp	169	CCA	"CCT,CYA"	P	"P,X"	ORF1ab	4539	CCA	"CCT,CYA"	P	"P,X"	4539	"NiRAN, NTD"		10.1126/science.abb7498 10.1093/nar/gkg916
"ORF1b 166,RdRp 176"	13966	13966	13968	GCC	ACC	A	T	2	0	"RdRp	176, ORF1a "	ORF1b	166	RdRp	176	GCC	ACC	A	T	ORF1ab	4546	GCC	ACC	A	T	4546	"NiRAN, NTD"		10.1093/nar/gkg916
"ORF1b 212,RdRp 222"	14104	14104	14106	TTC	CTC	F	L	2	0	"RdRp	222, ORF1a "	ORF1b	212	RdRp	222	TTC	CTC	F	L	ORF1ab	4592	TTC	CTC	F	L	4592	"NiRAN, NTD"		10.1093/nar/gkg916
"ORF1b 242,RdRp 252"	14194	14194	14196	Act	Gct	T	A	2	0	"RdRp 252, ORF1a 4599"	ORF1b	242	RdRp	252	na	na	na	na	na	na	na	na			4622	"Interface domain, NTD"		10.1038/s41467-019-10280-3 10.1093/nar/gkg916
"ORF1b 257,RdRp 267"	14239	14239	14241	AAG	AAT	K	N	2	0	"RdRp	267, ORF1a "	ORF1b	257	RdRp	267	AAG	AAT	K	N	ORF1ab	4637	AAG	AAT	K	N	4637	"Interface domain, NTD"		10.1038/s41467-019-10280-3 10.1093/nar/gkg916
"ORF1b 266,RdRp 276"	14266	14266	14268	ACG	ATG	T	M	2	0	"RdRp	276, ORF1a "	ORF1b	266	RdRp	276	ACG	ATG	T	M	ORF1ab	4646	ACG	ATG	T	M	4646	"Interface domain, NTD"		10.1038/s41467-019-10280-3 10.1093/nar/gkg916
"ORF1b 274,RdRp 284"	14290	14290	14292	GAC	TAC	D	Y	2	0	"RdRp	284, ORF1a "	ORF1b	274	RdRp	284	GAC	TAC	D	Y	ORF1ab	4654	GAC	TAC	D	Y	4654	"Interface domain, NTD"		10.1038/s41467-019-10280-3 10.1093/nar/gkg916
"ORF1b 313,RdRp 323"	14407	14407	14409	"CTT,CCT,TTT"	"CCT,TTT,CYT,TCT,CNT,ACT"	"L,P,F"	"P,F,X,S,T"	6	0	RdRp 323 ORF1ab 4670	ORF1b	313	RdRp	323	"CTT,CCT,TTT"	"CCT,TTT,CYT,TCT,CNT,ACT"	"L,P,F"	"P,F,X,S,T"	ORF1ab	4693	"CTT,CCT,TTT"	"CCT,TTT,CYT,TCT,CNT,ACT"	"L,P,F"	"P,F,X,S,T"	4693	"Interface domain, Observed stable mutation in Europe (mostly) and North America, NTD"		"10.1186/s12967-020-02344-6, 10.1038/s41467-019-10280-3, 10.1016/j.ygeno.2020.04.016 10.1093/nar/gkg916"
"ORF1b 395,RdRp 405"	14653	14653	14655	GTT	"TTT,ATT"	V	"F,I"	2	0	"RdRp	405, ORF1a "	ORF1b	395	RdRp	405	GTT	"TTT,ATT"	V	"F,I"	ORF1ab	4775	GTT	"TTT,ATT"	V	"F,I"	4775	"C-ter portion, “right hand” RdRp domain, Fingers Domain"		"10.1093/nar/gkg916, 10.1126/science.abb7498, 10.1093/nar/gkg916"
"ORF1b 418,RdRp 428"	14722	14722	14724	TTC	"TTT,TTY"	F	F	2	0	"RdRp	428, ORF1a "	ORF1b	418	RdRp	428	TTC	"TTT,TTY"	F	F	ORF1ab	4798	TTC	"TTT,TTY"	F	F	4798	"C-ter portion, “right hand” RdRp domain, Fingers Domain"		"10.1093/nar/gkg916, 10.1126/science.abb7498, 10.1093/nar/gkg916"
"ORF1b 445,RdRp 455"	14803	14803	14805	"TAC,TAT"	"TAT,TAY,TAN,NNC"	Y	"Y,X"	2	0	"RdRp	455, ORF1a "	ORF1b	445	RdRp	455	"TAC,TAT"	"TAT,TAY,TAN,NNC"	Y	"Y,X"	ORF1ab	4825	"TAC,TAT"	"TAT,TAY,TAN,NNC"	Y	"Y,X"	4825	"C-ter portion, “right hand” RdRp domain, Fingers Domain"		"10.1093/nar/gkg916, 10.1126/science.abb7498, 10.1093/nar/gkg916"
"ORF1b 462,RdRp 472"	14854	14854	14856	GTA	"GTG,NNN,GTT"	V	"V,X"	2	0	"RdRp	472, ORF1a "	ORF1b	462	RdRp	472	GTA	"GTG,NNN,GTT"	V	"V,X"	ORF1ab	4842	GTA	"GTG,NNN,GTT"	V	"V,X"	4842	"C-ter portion, Domain G (Positioning of template overhang), “right hand” RdRp domain"		"10.1093/nar/gkg916, 10.1126/science.abb7498"
"ORF1b 490,RdRp 500"	14938	14938	14940	AAA	"AAG,NAA"	K	"K,X"	2	0	"RdRp	500, ORF1a "	ORF1b	490	RdRp	500	AAA	"AAG,NAA"	K	"K,X"	ORF1ab	4870	AAA	"AAG,NAA"	K	"K,X"	4870	"C-ter portion, Fingers Domain,  Interaction with RNA, “right hand” RdRp domain"		"10.1093/nar/gkg916, 10.1038/s41586-020-2368-8, 10.1126/science.abb7498"
"ORF1b 566,RdRp 576"	15166	15166	15168	"TTG,CTG"	"CTG,TTR,YTG"	L	L	2	0	"RdRp	576, ORF1a "	ORF1b	566	RdRp	576	"TTG,CTG"	"CTG,TTR,YTG"	L	L	ORF1ab	4946	"TTG,CTG"	"CTG,TTR,YTG"	L	L	4946	"C-ter portion, Fingers Domain, “right hand” RdRp domain"		"10.1093/nar/gkg916, 10.1038/s41586-020-2368-8, 10.1126/science.abb7498"
"ORF1b 603,RdRp 613"	15277	15277	15279	CAC	TAC	H	Y	5	0	"RdRp 613, ORF1a 4960"	ORF1b	603	RdRp	613	CAC	TAC	H	Y	ORF1ab	4983	CAC	TAC	H	Y	4983	"RdRp domain; Palm domain, A motif, tested for resistance to ntp analogues antiviral, no impact., C-ter portion, “right hand” RdRp domain"		"10.1128/JVI.00080-16, 10.1126/science.abb7498, 10.1038/s41467-019-10280-3 10.1093/nar/gkg916, 10.1126/science.abb7498"
"ORF1b 618,RdRp 628"	15322	15322	15324	"AAC,AAT"	"AAT,AAY"	N	N	2	0	"RdRp	628, ORF1a "	ORF1b	618	RdRp	628	"AAC,AAT"	"AAT,AAY"	N	N	ORF1ab	4998	"AAC,AAT"	"AAT,AAY"	N	N	4998	"RdRp domain;, C-ter portion; Palm domain, “right hand” RdRp domain"		"10.1126/science.abb7498, 10.1038/s41467-019-10280-3 10.1093/nar/gkg916, 10.1038/s41586-020-2368-8, 10.1126/science.abb7498"
"ORF1b 637,RdRp 647"	15379	15379	15381	"AGC,ATC"	"ATC,AKC,ANC"	"S,I"	"I,X"	2	0	"RdRp	647, ORF1a "	ORF1b	637	RdRp	647	"AGC,ATC"	"ATC,AKC,ANC"	"S,I"	"I,X"	ORF1ab	5017	"AGC,ATC"	"ATC,AKC,ANC"	"S,I"	"I,X"	5017	"RdRp domain; C-ter portion; Palm domain, “right hand” RdRp domain"		"10.1126/science.abb7498, 10.1038/s41467-019-10280-3 10.1093/nar/gkg916, 10.1038/s41586-020-2368-8, 10.1126/science.abb7498"
"ORF1b 652,RdRp 662"	15424	15424	15426	GTA	GTG	V	V	2	0	"RdRp	662, ORF1a "	ORF1b	652	RdRp	662	GTA	GTG	V	V	ORF1ab	5032	GTA	GTG	V	V	5032	"RdRp domain; C-ter portion; Palm domain, “right hand” RdRp domain"		"10.1126/science.abb7498, 10.1038/s41467-019-10280-3 10.1093/nar/gkg916, 10.1038/s41586-020-2368-8, 10.1126/science.abb7498"
"ORF1b 746,RdRp 756"	15706	15706	15708	ATG	"ATT,ATC"	M	I	4	0	"RdRp	756, ORF1a "	ORF1b	746	RdRp	756	ATG	"ATT,ATC"	M	I	ORF1ab	5126	ATG	"ATT,ATC"	M	I	5126	"RdRp domain; Palm;, C-ter portion, C Domain, “right hand” RdRp domain"		"10.1126/science.abb7498, 10.1038/s41467-019-10280-3 10.1093/nar/gkg916"
"ORF1b 870,RdRp 880"	16078	16078	16080	GTC	"ATC,NNN"	V	"I,X"	2	0	"RdRp	880, ORF1a "	ORF1b	870	RdRp	880	GTC	"ATC,NNN"	V	"I,X"	ORF1ab	5250	GTC	"ATC,NNN"	V	"I,X"	5250	"C-ter portion, “right hand” RdRp domain"		"10.1093/nar/gkg916, 10.1126/science.abb7498"
"ORF1b 1022,helicase 100"	16534	16534	16536	AGC	"ATC,GGC"	S	"I,G"	6	0	"helicase 100, ORF1a  5402"	ORF1b	1022	helicase	100	AGC	"ATC,GGC"	S	"I,G"	ORF1ab	5402	AGC	"ATC,GGC"	S	"I,G"	5402	superfamily 1 helicase		10.3389/fmicb.2019.01813 10.1093/nar/gkg916
"ORF1b 1098,helicase 176"	16762	16762	16764	CTT	"TTT,YTT"	L	"F,X"	2	0		ORF1b	1098	helicase	176	CTT	"TTT,YTT"	L	"F,X"	ORF1ab	5478	CTT	"TTT,YTT"	L	"F,X"	5478	superfamily 1 helicase		10.3389/fmicb.2019.01813 10.1093/nar/gkg916
"ORF1b 1175,helicase 253"	16993	16993	16995	TAC	CAC	Y	H	2	0		ORF1b	1175	helicase	253	TAC	CAC	Y	H	ORF1ab	5555	TAC	CAC	Y	H	5555	superfamily 1 helicase		10.3389/fmicb.2019.01813 10.1093/nar/gkg916
"ORF1b 1218,helicase 296"	17122	17122	17124	GCT	"TCT,ACT"	A	"S,T"	2	0		ORF1b	1218	helicase	296	GCT	"TCT,ACT"	A	"S,T"	ORF1ab	5598	GCT	"TCT,ACT"	A	"S,T"	5598	superfamily 1 helicase		10.3389/fmicb.2019.01813 10.1093/nar/gkg916
"ORF1b 1219,helicase 297"	17125	17125	17127	CTC	"CCC,TTC,ATC"	L	"P,F,I"	4	0	"helicase 297, ORF1a  5599"	ORF1b	1219	helicase	297	CTC	"CCC,TTC,ATC"	L	"P,F,I"	ORF1ab	5599	CTC	"CCC,TTC,ATC"	L	"P,F,I"	5599	superfamily 1 helicase		10.3389/fmicb.2019.01813
"ORF1b 1241,helicase 319"	17191	17191	17193	GAG	GAT	E	D	2	0	"helicase 319, ORF1a 5621"	ORF1b	1241	helicase	319	GAG	GAT	E	D	ORF1ab	5621	GAG	GAT	E	D	5621	superfamily 1 helicase		10.3389/fmicb.2019.01813
"ORF1b 1259,helicase 337"	17245	17245	17247	CGT	"CGC,CGY,CGG"	R	R	4	0		ORF1b	1259	helicase	337	CGT	"CGC,CGY,CGG"	R	R	ORF1ab	5639	CGT	"CGC,CGY,CGG"	R	R	5639	superfamily 1 helicase		10.3389/fmicb.2019.01813
"ORF1b 1270,helicase 348"	17278	17278	17280	0	0	V	L	7	0	"helicase 348, ORF1a 5650"	ORF1b	1270	helicase	348	na	na	na	na	na	na	na	na	na	na	5757	superfamily 1 helicase		10.3389/fmicb.2019.01813
"ORF1b 1388,helicase 466"		17632	17634	GAC	"AAC,GAA"	D	"N,E"	2	0		ORF1b	1388	helicase	466	GAC	"AAC,GAA"	D	"N,E"	ORF1ab	5768	GAC	"AAC,GAA"	D	"N,E"	5768			
"ORF1b 1426,helicase 504"	17746	17746	17748	cCt	cTt	P	L	2	0	"helicase 504, ORF1ab 5806"	ORF1b	1426	helicase	504	na	na	na	na	na	na	na	na	na	na	5829	"North America Mutation. other mutations more likely to appear, superfamily 1 helicase"		"10.1186/s12967-020-02344-6; 10.3389/fmicb.2019.01813, 10.1016/j.ygeno.2020.04.016, "
"ORF1b 1432,helicase 510"	17764	17764	17766	GTC	"GTT,GTY"	V	V	2	0		ORF1b	1432	helicase	510	GTC	"GTT,GTY"	V	V	ORF1ab	5812	GTC	"GTT,GTY"	V	V	5812	superfamily 1 helicase		10.3389/fmicb.2019.01813
"ORF1b 1443,helicase 521"	17797	17797	17799	GTA	GTG	V	V	4	0		ORF1b	1443	helicase	521	GTA	GTG	V	V	ORF1ab	5823	GTA	GTG	V	V	5823	superfamily 1 helicase		10.3389/fmicb.2019.01813
"ORF1b 1452,helicase 530"	17824	17824	17826	aCt	aTt	T	I	2	0	"helicase 530, ORF1a 5832"	ORF1b	1452	helicase	530	na	na	na	na	na	na	na	na			5855	superfamily 1 helicase		10.3389/fmicb.2019.01813
"ORF1b 1472,helicase 550"	17884	17884	17886	0	0	T	A	3	0	"helicase 550, ORF1a 5852"	ORF1b	1472	helicase	550	na	na	na	na	na	na	na	na			5875	superfamily 1 helicase		10.3389/fmicb.2019.01813
"ORF1b 1538,3'-to-5' exonuclease 15"	18082	18082	18084	ATC	"ACC,GTC"	I	"T,V"	2	0		ORF1b	1538	3'-to-5' exonuclease	15	ATC	"ACC,GTC"	I	"T,V"	ORF1ab	5918	ATC	"ACC,GTC"	I	"T,V"	5918	N-terminal ExoN domain		"10.3389/fmicb.2019.01813, 10.1016/j.virusres.2017.01.023"
"ORF1b 1549,3'-to-5' exonuclease 26"	18115	18115	18117	"CAC,TAC"	"TAC,YAC"	"H,Y"	"Y,X"	2	0		ORF1b	1549	3'-to-5' exonuclease	26	"CAC,TAC"	"TAC,YAC"	"H,Y"	"Y,X"	ORF1ab	5929	"CAC,TAC"	"TAC,YAC"	"H,Y"	"Y,X"	5929	N-terminal ExoN domain		"10.3389/fmicb.2019.01813, 10.1016/j.virusres.2017.01.023"
"ORF1b 1680,3'-to-5' exonuclease 157"	18508	18508	18510	CTT	TTT	L	F	2	0		ORF1b	1680	3'-to-5' exonuclease	157	CTT	TTT	L	F	ORF1ab	6060	CTT	TTT	L	F	6060	N-terminal ExoN domain		"10.3389/fmicb.2019.01813, 10.1016/j.virusres.2017.01.023"
"ORF1b 1728,3'-to-5' exonuclease 205"	18652	18652	18654	CGC	"TGC,CTC"	R	"C,L"	4	0	ORF1a 6108	ORF1b	1728	3'-to-5' exonuclease	205	CGC	"TGC,CTC"	R	"C,L"	ORF1ab	6108	CGC	"TGC,CTC"	R	"C,L"	6108	N-terminal ExoN domain		"10.1016/j.virusres.2017.01.023,1 0.3389/fmicb.2019.01813"
"ORF1b 1739,3'-to-5' exonuclease 216"	18685	18685	18687	TGC	TTC	C	F	6	0	ORF1a 6119	ORF1b	1739	3'-to-5' exonuclease	216	TGC	TTC	C	F	ORF1ab	6119	TGC	TTC	C	F	6119	"Partially conserved residue, N-terminal ExoN domain"		"10.3389/fmicb.2019.01813, 10.1016/j.virusres.2017.01.023"
"ORF1b 1756,3'-to-5' exonuclease 233"	18736	18736	18738	Ttt	Ctt	F	L	3	0	ORF1a 5903	ORF1b	1756	3'-to-5' exonuclease	233	na	na	na	na	na	na	na	na			5926	N-terminal ExoN domain		"10.1016/j.virusres.2017.01.023, 10.3389/fmicb.2019.01813"
"ORF1b 1762,3'-to-5' exonuclease 239"	18754	18754	18756	CCG	"CCT,GCG,CCK,CCA"	P	"P,A"	2	0		ORF1b	1762	3'-to-5' exonuclease	239	CCG	"CCT,GCG,CCK,CCA"	P	"P,A"	ORF1ab	6142	CCG	"CCT,GCG,CCK,CCA"	P	"P,A"	6142	N-terminal ExoN domain		"10.3389/fmicb.2019.01813, 10.1016/j.virusres.2017.01.023"
"ORF1b 1803,3'-to-5' exonuclease 280"	18877	18877	18879	CTA	"TTA,YTA"	L	L	2	0		ORF1b	1803	3'-to-5' exonuclease	280	CTA	"TTA,YTA"	L	L	ORF1ab	6183	CTA	"TTA,YTA"	L	L	6183	N-terminal ExoN domain		"10.3389/fmicb.2019.01813, 10.1016/j.virusres.2017.01.023"
"ORF1b 1838,3'-to-5' exonuclease 315"	18982	18982	18984	ATG	"ATN,ATT,ATC"	M	"X,I"	2	0		ORF1b	1838	3'-to-5' exonuclease	315	ATG	"ATN,ATT,ATC"	M	"X,I"	ORF1ab	6218	ATG	"ATN,ATT,ATC"	M	"X,I"	6218	C- terminal N7-methyl transferase domain		"10.3389/fmicb.2019.01813, 10.1016/j.virusres.2017.01.023"
"ORF1b 1894,3'-to-5' exonuclease 371"	19150	19150	19152	GCC	GTC	A	V	2	0		ORF1b	1894	3'-to-5' exonuclease	371	GCC	GTC	A	V	ORF1ab	6274	GCC	GTC	A	V	6274	C- terminal N7-methyl transferase domain		"10.3389/fmicb.2019.01813, 10.1016/j.virusres.2017.01.023"
"ORF1b 1974,3'-to-5' exonuclease 451"	19390	19390	19392	CCA	"CCC,CCG,CNA,CTA"	P	"P,X,L"	2	0		ORF1b	1974	3'-to-5' exonuclease	451	CCA	"CCC,CCG,CNA,CTA"	P	"P,X,L"	ORF1ab	6354	CCA	"CCC,CCG,CNA,CTA"	P	"P,X,L"	6354	C- terminal N7-methyl transferase domain		"10.3389/fmicb.2019.01813, 10.1016/j.virusres.2017.01.023"
"ORF1b 2005,3'-to-5' exonuclease 482"	19483	19483	19485	"GCT,GTT"	"GTT,GNT,GYT"	"A,V"	"V,X"	2	0		ORF1b	2005	3'-to-5' exonuclease	482	"GCT,GTT"	"GTT,GNT,GYT"	"A,V"	"V,X"	ORF1ab	6385	"GCT,GTT"	"GTT,GNT,GYT"	"A,V"	"V,X"	6385	C- terminal N7-methyl transferase domain		"10.3389/fmicb.2019.01813, 10.1016/j.virusres.2017.01.023"
"ORF1b 2123,endoRNAse 73"	19837	19837	19839	"AAT,AAC"	"AAC,AAY"	N	N	2	0		ORF1b	2123	endoRNAse	73	"AAT,AAC"	"AAC,AAY"	N	N	ORF1ab	6503	"AAT,AAC"	"AAC,AAY"	N	N	6503	central domain		
"ORF1b 2142,endoRNAse 92"	19894	19894	19896	gaT	gaC	D	D	2	0	ORF1a 6522	ORF1b	2142	endoRNAse	92	na	na	na	na	na	na	na	na			6545	"uridine-specific endoribonuclease, EndoU uridylate-specific endoribonuclease, XendoU homolog, central domain"		"10.1016/j.virusres.2017.01.023, 10.1371/journal.ppat.1000428, 10.3389/fmicb.2019.01813, 10.1016/S0022-2836(03)00865-9, 10.1073/pnas.0601708103"
"ORF1b 2266,endoRNAse 216"	20266	20266	20268	TTA	"TTG,TTR"	L	L	2	0		ORF1b	2266	endoRNAse	216	TTA	"TTG,TTR"	L	L	ORF1ab	6646	TTA	"TTG,TTR"	L	L	6646	 C-terminal Domain		
"ORF1b 2269,endoRNAse 219"	20275	20275	20277	GAT	"TAT,AAT,GGT"	D	"Y,N,G"	3	0	ORF1a 6649	ORF1b	2269	endoRNAse	219	GAT	"TAT,AAT,GGT"	D	"Y,N,G"	ORF1ab	6649	GAT	"TAT,AAT,GGT"	D	"Y,N,G"	6649	"uridine-specific endoribonuclease, Mutation reported, wild type phenotype, EndoU uridylate-specific endoribonuclease, XendoU homolog, C-terminal Domain"		"10.1073/pnas.0601708103, 10.1371/journal.ppat.1000428, 10.3389/fmicb.2019.01813, 10.1016/S0022-2836(03)00865-9, 10.1073/pnas.0601708103"
"ORF1b 2457,2'-O-ribose methyltransferase 61"	20839	20839	20841	GTA	"GTG,GTT"	V	V	2	0		ORF1b	2457	2'-O-ribose methyltransferase	61	GTA	"GTG,GTT"	V	V	ORF1ab	6837	GTA	"GTG,GTT"	V	V	6837			
"ORF1b 2458,2'-O-ribose methyltransferase 62"	20842	20842	20844	CCC	"CCT,CCA,CCY"	P	P	2	0		ORF1b	2458	2'-O-ribose methyltransferase	62	CCC	"CCT,CCA,CCY"	P	P	ORF1ab	6838	CCC	"CCT,CCA,CCY"	P	P	6838			
"ORF1b 2530,2'-O-ribose methyltransferase 134"	21058	21058	21060	CCT	TCT	P	S	2	0		ORF1b	2530	2'-O-ribose methyltransferase	134	CCT	TCT	P	S	ORF1ab	6910	CCT	TCT	P	S	6910			
"ORF1b 2556,2'-O-ribose methyltransferase 160"	21136	21136	21138	AAG	"AGG,ARG"	K	"R,X"	2	0	ORF1a 6936	ORF1b	2556	2'-O-ribose methyltransferase	160	AAG	"AGG,ARG"	K	"R,X"	ORF1ab	6936	AAG	"AGG,ARG"	K	"R,X"	6936	core MTase domain		10.1371/journal.ppat.1002294
"ORF1b 2591,2'-O-ribose methyltransferase 195"	21241	21241	21243	0	0	T	I	5	0	ORF1a 6971	ORF1b	2591	2'-O-ribose methyltransferase	195	na	na	na	na	na	na	na	na			6994	core MTase domain		10.1371/journal.ppat.1002294
"ORF1b 2595,2'-O-ribose methyltransferase 199"	21253	21253	21255	GCG	"GCT,GCC,GCN,GCA"	A	A	2	0		ORF1b	2595	2'-O-ribose methyltransferase	199	GCG	"GCT,GCC,GCN,GCA"	A	A	ORF1ab	6975	GCG	"GCT,GCC,GCN,GCA"	A	A	6975			
"ORF1b 2612,2'-O-ribose methyltransferase 216"	21304	21304	21306	0	0	R	N	2	0	ORF1a  6992	ORF1b	2612	2'-O-ribose methyltransferase	216	na	na	na	na	na	na	na	na			7015			
S 29	21647	21647	21649	ACT	"ATT,NCT"	T	"I,X"	4	0	33	S	29	na	na	na	na	na	na	na	na	na	na	na	na		N-terminal Domain		
S 61	21743	21743	21745	AAT	AAC	N	N	2	0	65	S	61	na	na	na	na	na	na	na	na	na	na	na	na		N-terminal Domain		
S 76	21788	21788	21790	0	0	T	I	6	0	-	S	76	NL63 -	na	na	na	na	na	na	na	na	na				N-terminal Domain		
S 95	21845	21845	21847	0	0	T	I	6	0	92	S	95	NL63 100	na	na	na	na	na	na	na	na	na				N-terminal Domain		
S 138	21974	21974	21976	GAT	"GAC,CAT,RAT,GAN,TAT"	D	"D,H,B,X,Y"	2	0	135	S	138	na	na	na	na	na	na	na	na	na	na	na	na				
S 144	21992	21992	21994	0	0	V	D	2	0	141	S	144	NL63 -		na	na	na	na	na	na	na	na						
S 231	22253	22253	22255	ATA	ACC	I	T	2	0	224	S	231	na	na	na	na	na	na	na	na	na	na	na	na				
S 294	22442	22442	22444	GAC	"GAT,GNC,NNN,GAN"	D	"D,X"	2	0	281	S	294	na	na	na	na	na	na	na	na	na	na	na	na				
S 367	22661	22661	22663	gtC	gtT	V	V	12	0	354	S	367	NL63 508		na	na	na	na	na	na	na	na				RBD		
S 439	22877	22877	22879	0	0	N	K	4	0	426	S	439	NL63 557		na	na	na	na	na	na	na	na				"RBD, RBM, Variable residues between SARS-CoV-2 and SARS-CoV, critical residues in Polyclonal anti-SARS-1 antibodies and different between SARS-CoV-2 and SARS-CoV RBDs, ACE2-binding residue, SARS-CoV-derived discontinuous B cell epitopes associated with antibody m396"	"Could impact Response to antibodies, Residue reported to decrease ACE2 Binding when mutated in SARS"	"10.1038/s41423-020-0400-4, 10.1038/s41467-020-15562-9, doi.org/10.1038/s41423-020-0374-2, 10.1186/1743-422X-2-73, 10.1126/science.abb7269, 10.3390/v12030254"
S 598	23354	23354	23356	ATA	ATT	I	I	2	0	584	S	598	na	na	na	na	na	na	na	na	na	na	na	na		"HLA-DRB1*01:01, B cell epitope region"		"10.3390/v12030254, 10.1016/j.chom.2020.03.002"
S 614	23402	23402	23404	"AAA,GAT,GGT"	"GGT,GAT,GRT,GNT,AAT"	"K,D,G"	"G,D,X,N"	7	0	600	S	614	na	na	na	na	na	na	na	na	na	na	na	na		"B cell epitope region, North America Mutation, other mutations more likely to appear"		"10.1016/j.chom.2020.03.002, 10.1016/j.ygeno.2020.04.016, "
S 620	23420	23420	23422	GTC	"GTT,GTA,GTY"	V	V	2	0	606	S	620	na	na	na	na	na	na	na	na	na	na	na	na		B cell epitope region		10.1016/j.chom.2020.03.002
S 623	23429	23429	23431	GCT	"TCT,GTT"	A	"S,V"	2	0	609	S	623	na	na	na	na	na	na	na	na	na	na	na	na		B cell epitope region		10.1016/j.chom.2020.03.002
S 675	23585	23585	23587	CAG	"CAC,CGG,CAT,AAG"	Q	"H,R,K"	2	0	661	S	675	na	na	na	na	na	na	na	na	na	na	na	na				
S 723	23729	23729	23731	ACC	"ACT,ATC,ACY"	T	"T,I"	2	0	705	S	723	na	na	na	na	na	na	na	na	na	na	na	na		T Cell Epitopes		10.1016/j.chom.2020.03.002
S 731	23753	23753	23755	"ATG,ATT"	"ATT,ATC,NNN"	"M,I"	"I,X"	2	0	713	S	731	na	na	na	na	na	na	na	na	na	na	na	na				
S 824	24032	24032	24034	"AAC,AAT"	"AAT,AAY,AGC"	N	"N,S"	2	0	806	S	824	na	na	na	na	na	na	na	na	na	na	na	na		B cell epitope region		10.1016/j.chom.2020.03.002
S 934	24362	24362	24364	"ATT,ATC"	"ATC,ATA,ATG"	I	"I,M"	2	0	916	S	934	na	na	na	na	na	na	na	na	na	na	na	na				
S 936		24368	24370	"GAC,TAC,CAC"	"TAC,GAT,CAC,GAY,GAN,SAC"	"D,Y,H"	"Y,D,H,X"	3	0		S	936	na	na	na	na	na	na	na	na	na	na	na	na				
S 943	24389	24389	24391	0	0	S	"P,T"	12	0	925	S	943	NL63 1009		na	na	na	na	na	na	na	na				"T cell epitope, Epitope HLA locus A group 2 subtype 2:01, “HR1”, Fusion Core :  target of fusion/entry inhibitors, One of the 8 residues that differs from SARS-Cov Fusion Core , position f in the heptad repeat abcdefg pattern, "	"T variant more similar to SARS-1 fusion Core, Change in impact of fusion/entry inhibitor drugs, little to no impact expected on HR structure"	"10.1101/2020.03.30.016931, 10.1016/j.chom.2020.03.002, 10.1038/s41423-020-0374-2,10.1016/j.virol.2005.02.022, 10.1016/S0140-6736(04)15788-7"
S 1044	24692	24692	24694	GGA	"GGT,GGM"	G	G	2	0	1026	S	1044	na	na	na	na	na	na	na	na	na	na	na	na		"HLA-B*15:01, HLA-B*27:05, HLA-B*58:01, HLA-C*15:02,  T Cell Epitopes"		"10.3390/v12030254, 10.1016/j.chom.2020.03.002"
S 1100	24860	24860	24862	ACA	ACG	T	T	2	0	1082	S	1100	na	na	na	na	na	na	na	na	na	na	na	na		HLA-DRB1*01:01		10.3390/v12030254
ORF3a 14	25432	25432	25434	0	0	T	I	10	0	14	ORF3a	14	na		na	na	na	na	na	na	na	na				" T cell epitope, Epitope HLA locus B group 2 58:01:00"	Deleterious Mutation 	"10.1101/2020.03.30.016931, 10.1016/j.chom.2020.03.002, 10.1128/mSystems.00266-20"
ORF3a 42	25516	25516	25518	"CCT,CTT"	"CTT,TCT,CYT,NNN,MCT,CNT"	"P,L"	"L,S,X"	2	0	42	ORF3a	42	na	na	na	na	na	na	na	na	na	na	na	na				
ORF3a 43	25519	25519	25521	"TTC,TTT"	"TTT,TTY,YTC,ATC,NNN"	F	"F,X,I"	2	0	43	ORF3a	43	na	na	na	na	na	na	na	na	na	na	na	na				
ORF3a 54	25552	25552	25554	0	0	A	"S,V,T"	6	0	54	ORF3a	54	na	na	na	na	na	na	na	na	na	na					Neutral mutation	10.1128/mSystems.00266-20
ORF3a 57	25561	25561	25563	"CAG,CAT"	"CAT,CAK,CAC"	"Q,H"	"H,X"	6	0	57	ORF3a	57	na	na	na	na	na	na	na	na	na	na	na	na				
ORF3a 68	25594	25594	25596	AGA	"ATA,AGG,CGA,AKA"	R	"I,R,X"	2	0	68	ORF3a	68	na	na	na	na	na	na	na	na	na	na	na	na				
ORF3a 86	25648	25648	25650	0	0	L	F	4	0	86	ORF3a	86	na	na	na	na	na	na	na	na	na	na				"Cystein rich domain,"		"10.1016/j.antiviral.2014.06.013,"
ORF3a 95	25675	25675	25677	0	0	L	"F,S"	2	0	95	ORF3a	95	na	na	na	na	na	na	na	na	na	na				"Cystein rich domain, K+ ion channel"		"10.1016/j.antiviral.2014.06.013, 10.1128/mSystems.00266-20"
ORF3a 99	25687	25687	25689	"GCT,GTT"	"GTT,TCT,GYT,ACT,GAT,CCT"	"A,V"	"V,S,X,T,D,P"	7	0	99	ORF3a	99	na	na	na	na	na	na	na	na	na	na	na	na		"Cystein rich domain, K+ ion channel"	Neutral mutation	"10.1016/j.antiviral.2014.06.013, 10.1128/mSystems.00266-20, 10.1128/mSystems.00266-20"
ORF3a 107	25711	25711	25713	cTt	cCt	L	P	2	0	107	ORF3a	107	na	na	na	na	na	na	na	na	na	na				"Cystein rich domain, K+ ion channel"		"10.1016/j.antiviral.2014.06.013, 10.1128/mSystems.00266-20"
ORF3a 110	25720	25720	25722	0	0	A	"S,P,V"	3	0	110	ORF3a	110	na	na	na	na	na	na	na	na	na	na				"Cystein rich domain, K+ ion channel"		"10.1016/j.antiviral.2014.06.013, 10.1128/mSystems.00266-20"
ORF3a 125	25765	25765	25767	"ATG,ATT"	"ATT,ACG,ATK,AAG,ATC"	"M,I"	"I,T,X,K"	4	0	125	ORF3a	125	na	na	na	na	na	na	na	na	na	na	na	na		"Cystein rich domain, central region, bind to 5’UTR of SAR-Cov genome, K+ ion channel"	Neutral	"10.1016/j.antiviral.2014.06.013, 10.1128/mSystems.00266-20"
ORF3a 131	25783	25783	25785	"TGG,TTG,TGT"	"TGT,TTG,CGG,TCG,TGC,TGK"	"W,L,C"	"C,L,R,S,X"	4	0	131	ORF3a	131	na	na	na	na	na	na	na	na	na	na	na	na		"Cystein rich domain, , CWLCWKC region"	Deleterious	"10.1016/j.antiviral.2014.06.013, 10.1128/mSystems.00266-20"
ORF3a 140	25810	25810	25812	0	0	L	"F,V"	4	0	140	ORF3a	140	na	na	na	na	na	na	na	na	na	na				"Cystein rich domain,"	Neutral	10.1128/mSystems.00266-20
ORF3a 144	25822	25822	25824	0	0	N	D	4	0	144	ORF3a	144	na	na	na	na	na	na	na	na	na	na				"Cystein rich domain, central region, bind to 5’UTR of SAR-Cov genome, caveolin-binding motif"		10.1016/j.antiviral.2014.06.013
ORF3a 147	25831	25831	25833	0	0	L	F	5	0	147	ORF3a	147	na	na	na	na	na	na	na	na	na	na				"Cystein rich domain, central region, bind to 5’UTR of SAR-Cov genome, caveolin-binding motif"		10.1016/j.antiviral.2014.06.013
ORF3a 184	25942	25942	25944	0	0	Y	H	8	0	184	ORF3a	184	na	na	na	na	na	na	na	na	na	na						
ORF3a 223	26059	26059	26061	0	0	T	I	5	0	223	ORF3a	223	na	na	na	na	na	na	na	na	na	na				"C-ter domaine : induce cell cycle arrest, potential cytoplasmic region"		10.1016/j.antiviral.2014.06.013
ORF3a 239	26107	26107	26109	0	0	E	"D,G,V"	2	0	239	ORF3a	239	na	na	na	na	na	na	na	na	na	na				"C-ter domaine : induce cell cycle arrest, potential cytoplasmic region"		"10.1016/j.antiviral.2014.06.013,10.1016/j.jmb.2004.06.016"
ORF3a 240		26110	26112	"CCT,TCT"	"TCT,CTT,YCT,CYT"	"P,S"	"S,L,X"	2	0	240	ORF3a	240	na	na	na	na	na	na	na	na	na	na	na			na		
ORF3a 251	26143	26143	26145	0	0	G	"V,C"	12	0	251	ORF3a	250	na	na	na	na	na	na	na	na	na	na				"C-ter domaine : induce cell cycle arrest, Identified mutation, potential cytoplasmic region"	Deleterious Mutation (both)	"10.1016/j.antiviral.2014.06.013,10.1016/j.jmb.2004.06.016, 10.1128/mSystems.00266-20, 10.1186/s12967-020-02344-6, 10.1016/j.ygeno.2020.04.016, "
ORF3a 254	26152	26152	26154	0	0	G	R	3	0	254	ORF3a	253	na	na	na	na	na	na	na	na	na	na				"C-ter domaine : induce cell cycle arrest, potential cytoplasmic region"	Deleterious Mutation 	"10.1016/j.antiviral.2014.06.013,10.1016/j.jmb.2004.06.016, 10.1128/mSystems.00266-20"
ORF3a 271	26203	26203	26205	0	0	T	I	4	0	271	ORF3a	271	na	na	na	na	na	na	na	na	na					C-ter domaine : induce cell cycle arrest		"10.1016/j.antiviral.2014.06.013,10.1016/j.jmb.2004.06.016, 10.1128/mSystems.00266-20"
M 30	26610	26610	26612	"ACA,ACG"	"ACG,ACT"	T	T	2	0	29	M	30	na	na	na	na	na	na	na	na	na	na	na	na				
M 69	26727	26727	26729	"GCT,GCC"	"GCC,TCT,KCT,GCY"	A	"A,S,X"	2	0	68	M	69	na	na	na	na	na	na	na	na	na	na	na	na		T Cell Epitopes		10.1016/j.chom.2020.03.002
M 109	26847	26847	26849	"ATG,ATT"	"ATT,ATC,ATN"	"M,I"	"I,X"	2	0	108	M	109	na	na	na	na	na	na	na	na	na	na	na	na				
M 132	26916	26916	26918	CCG	"GCG,CCK,CCA,CCT,CCC"	P	"A,P"	2	0	131	M	132	na	na	na	na	na	na	na	na	na	na	na	na				
M 141	26943	26943	26945	"GGA,GGT"	"GGT,NGG"	G	"G,X"	2	0	140	M	141	na	na	na	na	na	na	na	na	na	na	na	na		B cell epitope region		10.1016/j.chom.2020.03.002
M 143	26949	26949	26951	GTG	"GTT,GTA,GTK,GNS"	V	"V,X"	2	0	142	M	143	na	na	na	na	na	na	na	na	na	na	na	na		B cell epitope region		10.1016/j.chom.2020.03.002
M 175	27045	27045	27047	0	0	T	"M,A"	8	0	174	M	175	na	na	na	na	na	na	na	na	na	na				"N Binding region, known mutation"		"10.1007/s11373-005-9035-9, 10.1016/j.ygeno.2020.04.016"
M 209	27147	27147	27149	0	0	D	"H,Y"	12	0	208	M	209	na	na	na	na	na	na	na	na	na	na						
ORF6 12	27147	27235	27237	0	0	A	T	9	0		ORF6	12	na	na	na	na	na	na	na	na	na	na						
ORF6 61	27235	27382	27384	gaT	gaC	D	D	2	0		ORF6	61	na	na	na	na	na	na	na	na	na	na						
ORF7a 70	27601	27601	27603	"GGC,GGT"	"GGT,TGC,GGA"	G	"G,C"	2	0		ORF7a	70	na	na	na	na	na	na	na	na	na	na	na	na				
ORF7a 92	27667	27667	27669	"GAA,GAG"	"GAG,GAR,GAT"	E	"E,D"	2	0		ORF7a	92	na	na	na	na	na	na	na	na	na	na	na	na				
ORF7a 121	27754	27754	27756	GAA	"GAW,GAG"	E	"X,E"	2	0		ORF7a	121	na	na	na	na	na	na	na	na	na	na	na	na				
ORF8 8		27915	27917	"GGA,AGA"	"AGA,GAA,RGA,GTA"	"G,R"	"R,E,X,V"	2	0		ORF8	8	na	na	na	na	na	na	na	na	na	na	na	na				
ORF8 51	28044	28044	28046	aGa	aTa	R	I	4	0		ORF8	51	na	na	na	na	na	na	na	na	na	na						
ORF8 65	28086	28086	28088	Ggt	Tgt	G	C	9	0		ORF8	65	na	na	na	na	na	na	na	na	na	na						
ORF8 67	28092	28092	28094	0	0	S	F	4	0		ORF8	67	na	na	na	na	na	na	na	na	na	na						
ORF8 84	28143	28143	28145	"TTA,TCA"	"TCA,TYA"	"L,S"	"S,X"	6	0		ORF8	84	na	na	na	na	na	na	na	na	na	na	na	na		Identified mutation		"10.1186/s12967-020-02344-6, 10.1016/j.ygeno.2020.04.016"
ORF8 85	28146	28146	28148	0	0	P	S	2	0		ORF8	85	na	na	na	na	na	na	na	na	na	na						
ORF8 121	28254	28254	28256	"ATC,TTC"	"CTC,TCT,TTC,NTC,MTC"	"I,F"	"L,S,F,X,J"	5	0		ORF8	121	na	na	na	na	na	na	na	na	na	na	na	na				
N 13	28310	28310	28312	"CCC,TCC,CTC"	"CTC,TCC,ACC,YCC,CGC,CYC"	"P,S,L"	"L,S,T,X,R"	6	0	14	N	13	na	na	na	na	na	na	na	na	na	na	na	na				
N 20	28331	28331	28333	CCC	"CTC,TCC"	P	"L,S"	4	0	22	N	20	na	na	na	na	na	na	na	na	na	na	na	na				
N 22	28337	28337	28339	0	0	D	"G,Y"	9	0	23	N	22	na	na	na	na	na	na	na	na	na	na						
N 24	28343	28343	28345	"ACT,ATT"	"ATT,AAT,AYT"	"T,I"	"I,N,X"	3	0	25	N	24	na	na	na	na	na	na	na	na	na	na	na	na				
N 34	28373	28373	28375	0	0	G	"E,W"	10	0	35	N	34	na	na	na	na	na	na	na	na	na	na						
N 36	28379	28379	28381	0	0	R	L	2	0	37	N	36	na	na	na	na	na	na	na	na	na	na						
N 55	28436	28436	28438	GCT	TCT	A	S	2	0	56	N	55	na	na	na	na	na	na	na	na	na	na	na	na		B cell epitope region		10.1016/j.chom.2020.03.002
N 67	28472	28472	28474	"CCT,TCT"	"TCT,CYT,ACT,CCY"	"P,S"	"S,X,T,P"	5	0	68	N	67	na	na	na	na	na	na	na	na	na	na	na	na		"linker region (LKR), U-shaped β-platform, putative RNA- binding domain, B-cell epitope   HLA-A*02:01 HLA-B*07:02 HLA-B*08:01 HLA-B*35:01 HLA-B*51:01 (identical in SARS-CoV-2 and SARS-Cov)"		"10.1128/jvi.00017-07 ,10.1016/j.jmb.2007.02.069, 10.3390/v12030254"
N 108	28595	28595	28597	TGG	"TGC,YGG"	W	"C,X"	5	0		N	108	na	na	na	na	na	na	na	na	na	na	na	na		"B-cell epitope  HLA-A*24:02, HLA-A*03:01,  HLA-A*11:01 HLA-A*68:01 HLA-A*23:01 HLA-A*31:01 (identical in SARS-CoV-2 and SARS-Cov)"		10.3390/v12030254
N 119	28628	28628	28630	GCT	"GTT,TCT"	A	"V,S"	5	0	120	N	119	na	na	na	na	na	na	na	na	na	na	na	na		"linker region (LKR), U-shaped β-platform, putative RNA- binding domain"		"10.1128/jvi.00017-07, 10.1016/j.jmb.2007.02.069"
N 139	28688	28688	28690	"TTG,CTG,TTT"	"CTG,TTT,YTG,TTK"	"L,F"	"L,F,X"	2	0	140	N	139	na	na	na	na	na	na	na	na	na	na	na	na				
N 144	28703	28703	28705	"GAT,TAT"	"TAT,CAT,AAT,KAT,GAG"	"D,Y"	"Y,H,N,X,E"	5	0	145	N	144	na	na	na	na	na	na	na	na	na	na	na	na		"linker region (LKR), U-shaped β-platform, T cell epitope, possible RNA binding , B-cell epitope HLA-A*02:01 HLA-A*11:01 HLA-A*68:01 HLA-A*31:01, T-cell epitope  HLA-A*02:01 (identical in SARS-CoV-2 and SARS-Cov)"		"10.1016/j.chom.2020.03.002 10.1128/jvi.00017-07, 10.1016/j.str.2005.08.021, 10.1016/j.jmb.2007.02.069, 10.3390/v12030254"
N 151	28724	28724	28726	"CCT,CTT"	"CTT,TCT,CAT,CYT"	"P,L"	"L,S,H,X"	5	0	152	N	151	na	na	na	na	na	na	na	na	na	na	na	na		"linker region (LKR), U-shaped β-platform, putative RNA- binding domain"		"10.1128/jvi.00017-07, 10.1016/j.jmb.2007.02.069"
N 173	28790	28790	28792	"GCA,GCG"	"GCG,GTA,GCT,GCN"	A	"A,V"	2	0	174	N	173	na	na	na	na	na	na	na	na	na	na	na	na				
N 180	28811	28811	28813	0	0	S	"I,C,G"	4	0	181	N	180	na	na	na	na	na	na	na	na	na	na				"linker region (LKR), U-shaped β-platform, putative RNA- binding domain; B-cell epitope HLA-A*33:01 HLA-A*11:01 HLA-A*68:01 HLA-A*31:01 (identical in SARS-CoV-2 and SARS-Cov)"		"10.1128/jvi.00017-07, 10.1016/j.jmb.2007.02.069, 10.3390/v12030254"
N 185	28826	28826	28828	0	0	R	"C,L,H"	3	0	186	N	185	na	na	na	na	na	na	na	na	na	na				"linker region (LKR), U-shaped β-platform, essential for multimerization of SARS-CoV N protein, Phosphorylation site in IBV, B-cell epitope HLA-A*11:01 HLA-A*68:01 HLA-A*31:01 (identical in SARS-CoV-2 and SARS-Cov)"		"10.1128/jvi.00017-07, 10.1016/j.str.2005.08.021, 10.1007/s11373-005-9035-9, 10.3390/v12030254"
N 190	28841	28841	28843	0	0	S	"I,G"	8	0	191	N	190	na	na	na	na	na	na	na	na	na	na				"linker region (LKR), U-shaped β-platform, essential for multimerization of SARS-CoV N protein, Phosphorylation site in IBV, B-cell epitope HLA-A*11:01 HLA-A*68:01 HLA-A*31:01 HLA-A*33:01 (identical in SARS-CoV-2 and SARS-Cov)"		"10.1128/jvi.00017-07, 10.1016/j.str.2005.08.021, 10.1007/s11373-005-9035-9, 10.3390/v12030254"
N 202	28877	28877	28879	aGg	aAg	R	K	9	0	203	N	202	na	na	na	na	na	na	na	na	na	na				"linker region (LKR), "		10.1128/jvi.00017-07
N 205	28886	28886	28888	0	0	T	I	5	0	206	N	205	na	na	na	na	na	na	na	na	na	na				"linker region (LKR), "		10.1128/jvi.00017-07
N 207		28892	28894	CCT	"CTT,CYT,NNT,CCN"	P	"L,X,P"	2	0	208	N	207	na	na	na	na	na	na	na	na	na	na	na	na				
N 208	28895	28895	28897	"GCT,TCT"	"GGT,TCT,GCN,NCT"	"A,S"	"G,S,A,X"	4	0	209	N	208	na	na	na	na	na	na	na	na	na	na	na	na		"linker region (LKR), "		10.1128/jvi.00017-07
N 210		28901	28903	ATG	"ACG,ATT,ACT"	M	"T,I"	2	0		N	210	na	na	na	na	na	na	na	na	na	na	na	na				
N 215	28916	28916	28918	0	0	G	S	2	0	216	N	215	na	na	na	na	na	na	na	na	na	na				"linker region (LKR), T cell epitope"		"10.1016/j.chom.2020.03.002, 10.1128/jvi.00017-07"
N 218	28925	28925	28927	GCT	"GTT,TCT"	A	"V,S"	5	0	219	N	218	na	na	na	na	na	na	na	na	na	na	na	na		"linker region (LKR), T cell epitope"		"10.1016/j.chom.2020.03.002, 10.1128/jvi.00017-07"
N 253	29030	29030	29032	GAG	"GAA,GGG,GAT,GAK,GNG"	E	"E,G,D,X"	2	0	254	N	253	na	na	na	na	na	na	na	na	na	na	na	na				
N 291	29144	29144	29146	CTA	"TTA,YTA"	L	L	2	0	292	N	291	na	na	na	na	na	na	na	na	na	na	na	na				
N 305	29186	29186	29188	GCA	"GCT,GYR"	A	"A,X"	2	0	306	N	305	na	na	na	na	na	na	na	na	na	na	na	na				
N 318	29225	29225	29227	TCG	"TCT,TCA"	S	S	2	0	319	N	318	na	na	na	na	na	na	na	na	na	na	na	na		T Cell Epitopes		10.1016/j.chom.2020.03.002
N 336	29279	29279	29281	0	0	A	V	5	0	337	N	336	na	na	na	na	na	na	na	na	na	na				"CTD, hydrophobic, helix-rich terminal, dimerization do- main, core stabilized by multiple hydrophobic interactions"		"10.1128/jvi.00017-07, 10.1016/j.jmb.2007.02.069"
N 344	29303	29303	29305	0	0	P	"S,L"	2	0	345	N	344	na	na	na	na	na	na	na	na	na	na				"CTD, hydrophobic, helix-rich terminal, dimerization do- main, core stabilized by multiple hydrophobic interactions"		"10.1128/jvi.00017-07, 10.1016/j.jmb.2007.02.069"
N 348	29315	29315	29317	0	0	D	"Y,H"	2	0	349	N	348	na	na	na	na	na	na	na	na	na	na				"CTD, hydrophobic, helix-rich terminal, T cell epitope, Epitope HLA locus A subtype  24:02:00, dimerization do- main, core stabilized by multiple hydrophobic interactions, extended b-strand"		"10.1101/2020.03.30.016931, 10.1016/j.chom.2020.03.002, 10.1128/jvi.00017-07, 10.1016/j.jmb.2007.02.069, 10.1007/s11373-005-9035-9"
N 360	29351	29351	29353	TAC	TAT	Y	Y	2	0		N	360	na	na	na	na	na	na	na	na	na	na	na	na		B cell epitope region		10.1016/j.chom.2020.03.002
N 368	29375	29375	29377	0	0	P	S	2	0	369	N	368	na	na	na	na	na	na	na	na	na	na				"B cell epitope region, Epitope HLA locus A subtype 11:01, core stabilized by multiple hydrophobic interactions, RNA binding region, Phosphorylation site in IBV, B-cell epitope  HLA-A*03:01 HLA-A*11:01 HLA-A*68:01 HLA-A*31:01 HLA-DRB1*01:01 (identical in SARS-CoV-2 and SARS-Cov)"		"10.1101/2020.03.30.016931, 10.1016/j.chom.2020.03.002, 10.1016/j.jmb.2007.02.069, 10.1007/s11373-005-9035-9, 0.3390/v12030254"
N 377		29402	29404	"GAT,TAT"	"TAT,GGT,CAT"	"D,Y"	"Y,G,H"	4	0		N	377	na	na	na	na	na	na	na	na	na	na	na	na				na
N 393	29450	29450	29452	ACT	ATT	T	I	5	0	394	N	393	na	na	na	na	na	na	na	na	na	na	na	na		"B cell epitope region, Phosphorylation site in IBV"		"10.1016/j.chom.2020.03.002, 10.1007/s11373-005-9035-9"
N 397	29462	29462	29464	"GCT,GTT"	"GTT,TCT,GNT"	"A,V"	"V,S,X"	2	0	398	N	397	na	na	na	na	na	na	na	na	na	na	na	na		B cell epitope region		10.1016/j.chom.2020.03.002
N 399	29468	29468	29470	0	0	D	Y	3	0	400	N	399	na	na	na	na	na	na	na	na	na	na				B cell epitope region		10.1016/j.chom.2020.03.002
N 402	29477	29477	29479	0	0	D	Y	6	0	403	N	402	na	na	na	na	na	na	na	na	na	na						
N 417	29522	29522	29524	ACT	ATT	T	I	2	0		N	417	na	na	na	na	na	na	na	na	na	na	na	na				
